{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:18:38Z","timestamp":1793974718065,"version":"4.8.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cytotoxic T-lymphocyte-associated protein 4 deficiency (CTLA4-D) is an inborn error of immunity (IEI) caused by heterozygous mutations, and characterized by immune cell infiltration into the gut and other organs, leading to intestinal disease, immune dysregulation and autoimmunity. While regulatory T-cell dysfunction remains central to CTLA4-D immunopathogenesis, mechanisms driving disease severity and intestinal pathology are unknown but likely involve intestinal\u00a0dysbiosis. We determined whether the intestinal microbiome and metabolome could distinguish individuals with severe CTLA4-D and identify biomarkers of disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The genera\n                      <jats:italic>Veillonella<\/jats:italic>\n                      and\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      emerged as biomarkers that distinguished CTLA4-D from healthy cohorts from both the National Institutes of Health (NIH) Clinical Center, USA (NIH; CTLA-D,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200932; healthy controls,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916), and a geographically distinct cohort from the Center for Chronic Immunodeficiency (CCI) of the\u00a0Medical Center\u00a0-\u00a0University of\u00a0Freiburg, Germany (CCI; CTLA4-D,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200925; healthy controls,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924). Since IEIs in general may be associated with perturbations of the microbiota, a disease control cohort of individuals with common variable immunodeficiency (CVID,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920) was included to evaluate for a CTLA4-D-specific microbial signature. Despite common IEI-associated microbiome changes, the two bacterial genera retained their specificity as biomarkers for CTLA4-D. We further identified intestinal microbiome and metabolomic signatures that distinguished patients with CTLA4-D having severe vs. mild disease. Microbiome changes were associated with distinct stool metabolomic profiles and predicted changes in metabolic pathways. These differences were impacted by the presence of gastrointestinal manifestations and were partially reversed by treatment with abatacept and\/or sirolimus.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Loss of intestinal\u00a0microbial diversity and dysbiosis causing metabolomic changes was observed in CTLA4-D. Albeit some of these features were shared with CVID, the distinct changes associated with CTLA4-D highlight the fact that IEI-associated microbiome changes likely reflect the underlying immune dysregulation. Identified candidate intestinal microbial and metabolic biomarkers distinguishing individuals with CTLA4-D based on severity should be studied prospectively to determine their predictive value, and investigated as potential therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40168-025-02028-7","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T10:05:51Z","timestamp":1739268351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency"],"prefix":"10.1186","volume":"13","author":[{"given":"Prabha","family":"Chandrasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1t\u00e9","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Mitsuiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Gabrysch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"N\u00f6ltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Grou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorani","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yik","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Deming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Conlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Segre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulbu","family":"Uzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5486-1549","authenticated-orcid":false,"given":"Emilia Liana","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"6","key":"2028_CR1","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.176.6.1595","volume":"176","author":"PS Linsley","year":"1992","unstructured":"Linsley PS, Greene JL, Tan P, Bradshaw J, Ledbetter JA, Anasetti C, Damle NK. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med. 1992;176(6):1595\u2013604.","journal-title":"J Exp Med"},{"issue":"2","key":"2028_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.182.2.459","volume":"182","author":"MF Krummel","year":"1995","unstructured":"Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med. 1995;182(2):459\u201365.","journal-title":"J Exp Med"},{"issue":"1","key":"2028_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085982","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Liu L, Ma J, Sun F, Zhao Z, Gu M. Common variants on cytotoxic T lymphocyte antigen-4 polymorphisms contributes to type 1 diabetes susceptibility: evidence based on 58 studies. PLoS ONE. 2014;9(1): e85982.","journal-title":"PLoS ONE"},{"issue":"5","key":"2028_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1399-0039.1998.tb02993.x","volume":"51","author":"J Braun","year":"1998","unstructured":"Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH, Badenhoop K. CTLA-4 promoter variants in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. Tissue Antigens. 1998;51(5):563\u20136.","journal-title":"Tissue Antigens"},{"issue":"4","key":"2028_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/sj.ejhg.5201357","volume":"13","author":"KA Hunt","year":"2005","unstructured":"Hunt KA, McGovern DP, Kumar PJ, Ghosh S, Travis SP, Walters JR, Jewell DP, Playford RJ, van Heel DA. A common CTLA4 haplotype associated with coeliac disease. Eur J Hum Genet. 2005;13(4):440\u20134.","journal-title":"Eur J Hum Genet"},{"issue":"6204","key":"2028_CR6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, Avery DT, Schickel JN, Tran DQ, Stoddard J, Zhang Y, et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science. 2014;345(6204):1623\u20137.","journal-title":"Science"},{"issue":"12","key":"2028_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","volume":"20","author":"D Schubert","year":"2014","unstructured":"Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, Bulashevska A, Petersen BS, Schaffer AA, Gruning BA, et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med. 2014;20(12):1410\u20136.","journal-title":"Nat Med"},{"issue":"3","key":"2028_CR8","first-page":"244","volume":"17","author":"F Zaremehrjardi","year":"2020","unstructured":"Zaremehrjardi F, Baniadam L, Seif F, Arshi S, Bemanian MH, Shokri S, Rezaeifar A, Fallahpour M, Nabavi M. A patient with CTLA-4 haploinsufficiency with multiple autoimmune presentations: a case report. Iran J Immunol. 2020;17(3):244\u20139.","journal-title":"Iran J Immunol"},{"issue":"6","key":"2028_CR9","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","volume":"142","author":"C Schwab","year":"2018","unstructured":"Schwab C, Gabrysch A, Olbrich P, Patino V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol. 2018;142(6):1932\u201346.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"2028_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","volume":"128","author":"B Lo","year":"2016","unstructured":"Lo B, Fritz JM, Su HC, Uzel G, Jordan MB, Lenardo MJ. CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency. Blood. 2016;128(8):1037\u201342.","journal-title":"Blood"},{"issue":"2","key":"2028_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jaci.2016.01.045","volume":"138","author":"MA Slatter","year":"2016","unstructured":"Slatter MA, Engelhardt KR, Burroughs LM, Arkwright PD, Nademi Z, Skoda-Smith S, Hagin D, Kennedy A, Barge D, Flood T, et al. Hematopoietic stem cell transplantation for CTLA4 deficiency. J Allergy Clin Immunol. 2016;138(2):615-619 e611.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2028_CR12","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jaip.2017.03.007","volume":"5","author":"P Makadia","year":"2017","unstructured":"Makadia P, Srinath A, Madan-Khetarpal S, McGuire M, Infante E, Zhang J, Felgar RE, Davis AW, Chong HJ, Windreich RM. Aplastic anemia and cytotoxic T lymphocyte antigen-4 haploinsufficiency treated with bone marrow transplantation. J Allergy Clin Immunol Pract. 2017;5(5):1445-1447.e1442.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"2028_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711\u201323.","journal-title":"N Engl J Med"},{"issue":"10","key":"2028_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/jamaoncol.2016.1051","volume":"2","author":"CF Friedman","year":"2016","unstructured":"Friedman CF, Proverbs-Singh TA, Postow MA. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review. JAMA Oncol. 2016;2(10):1346\u201353.","journal-title":"JAMA Oncol"},{"issue":"5","key":"2028_CR15","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.immuni.2011.03.021","volume":"34","author":"MB Geuking","year":"2011","unstructured":"Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, McCoy KD, Macpherson AJ. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity. 2011;34(5):794\u2013806.","journal-title":"Immunity"},{"issue":"6264","key":"2028_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M Vetizou","year":"2015","unstructured":"Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079\u201384.","journal-title":"Science"},{"issue":"6264","key":"2028_CR17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, et al. Commensal bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350(6264):1084\u20139.","journal-title":"Science"},{"issue":"1","key":"2028_CR18","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","volume":"11","author":"C Coutzac","year":"2020","unstructured":"Coutzac C, Jouniaux JM, Paci A, Schmidt J, Mallardo D, Seck A, Asvatourian V, Cassard L, Saulnier P, Lacroix L, et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat Commun. 2020;11(1):2168.","journal-title":"Nat Commun"},{"issue":"6510","key":"2028_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, Paik S, Stagg J, Groves RA, Gallo M, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 2020;369(6510):1481\u20139.","journal-title":"Science"},{"issue":"5","key":"2028_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s10620-012-2500-1","volume":"58","author":"B Surti","year":"2013","unstructured":"Surti B, Spiegel B, Ippoliti A, Vasiliauskas EA, Simpson P, Shih DQ, Targan SR, McGovern DP, Melmed GY. Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale. Dig Dis Sci. 2013;58(5):1313\u201321.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"2028_CR21","first-page":"1571","volume":"91","author":"EJ Irvine","year":"1996","unstructured":"Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn\u2019s Relapse Prevention Trial. Am J Gastroenterol. 1996;91(8):1571\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"2028_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.crohns.2012.11.007","volume":"7","author":"F Bennebroek Evertsz","year":"2013","unstructured":"Bennebroek Evertsz F, Nieuwkerk PT, Stokkers PC, Ponsioen CY, Bockting CL, Sanderman R, Sprangers MA. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohns Colitis. 2013;7(11):890\u2013900.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"2028_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-2-6","volume":"2","author":"DW Fadrosh","year":"2014","unstructured":"Fadrosh DW, Ma B, Gajer P, Sengamalay N, Ott S, Brotman RM, Ravel J. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome. 2014;2(1): 6.","journal-title":"Microbiome"},{"issue":"6","key":"2028_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold ME, Brimacombe KR, Chan SH, Rohde JM, Lewis CA, Swier LJ, Possemato R, Chen WW, Sullivan LB, Fiske BP, et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol. 2016;12(6):452\u20138.","journal-title":"Nat Chem Biol"},{"issue":"24","key":"2028_CR25","doi-asserted-by":"publisher","first-page":"11725","DOI":"10.1021\/ac402503m","volume":"85","author":"Y Simon-Manso","year":"2013","unstructured":"Simon-Manso Y, Lowenthal MS, Kilpatrick LE, Sampson ML, Telu KH, Rudnick PA, Mallard WG, Bearden DW, Schock TB, Tchekhovskoi DV, et al. Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. Anal Chem. 2013;85(24):11725\u201331.","journal-title":"Anal Chem"},{"issue":"18","key":"2028_CR26","doi-asserted-by":"publisher","first-page":"12021","DOI":"10.1021\/acs.analchem.9b02977","volume":"91","author":"Y Simon-Manso","year":"2019","unstructured":"Simon-Manso Y, Marupaka R, Yan X, Liang Y, Telu KH, Mirokhin Y, Stein SE. Mass spectrometry fingerprints of small-molecule metabolites in biofluids: building a spectral library of recurrent spectra for urine analysis. Anal Chem. 2019;91(18):12021\u20139.","journal-title":"Anal Chem"},{"issue":"6","key":"2028_CR27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/01.ftd.0000179845.53213.39","volume":"27","author":"CA Smith","year":"2005","unstructured":"Smith CA, O\u2019Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005;27(6):747\u201351.","journal-title":"Ther Drug Monit"},{"issue":"5","key":"2028_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/metabo10050190","volume":"10","author":"X Wang","year":"2020","unstructured":"Wang X, Cho JH, Poudel S, Li Y, Jones DR, Shaw TI, Tan H, Xie B, Peng J. JUMPm: a tool for large-scale identification of metabolites in untargeted metabolomics. Metabolites. 2020;10(5):190.","journal-title":"Metabolites"},{"issue":"7","key":"2028_CR29","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1021\/acs.jproteome.8b00019","volume":"17","author":"X Wang","year":"2018","unstructured":"Wang X, Jones DR, Shaw TI, Cho JH, Wang Y, Tan H, Xie B, Zhou S, Li Y, Peng J. Target-decoy-based false discovery rate estimation for large-scale metabolite identification. J Proteome Res. 2018;17(7):2328\u201334.","journal-title":"J Proteome Res"},{"issue":"7","key":"2028_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods"},{"key":"2028_CR31","unstructured":"McMurdie PJ, Holmes S. Phyloseq: a bioconductor package for handling and analysis of high-throughput phylogenetic sequence data. Pac Symp Biocomput. 2012:235\u201346."},{"issue":"6","key":"2028_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157022","volume":"11","author":"H Varet","year":"2016","unstructured":"Varet H, Brillet-Gueguen L, Coppee JY, Dillies MA. SARTools: a DESeq2- and EdgeR-based R pipeline for comprehensive differential analysis of RNA-seq data. PLoS ONE. 2016;11(6): e0157022.","journal-title":"PLoS ONE"},{"issue":"2","key":"2028_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005404","volume":"13","author":"ZS Foster","year":"2017","unstructured":"Foster ZS, Sharpton TJ, Grunwald NJ. Metacoder: an R package for visualization and manipulation of community taxonomic diversity data. PLoS Comput Biol. 2017;13(2): e1005404.","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"2028_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6): R60.","journal-title":"Genome Biol"},{"issue":"3","key":"2028_CR35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41596-019-0264-1","volume":"15","author":"J Chong","year":"2020","unstructured":"Chong J, Liu P, Zhou G, Xia J. Using microbiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data. Nat Protoc. 2020;15(3):799\u2013821.","journal-title":"Nat Protoc"},{"issue":"9","key":"2028_CR36","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814\u201321.","journal-title":"Nat Biotechnol"},{"issue":"W1","key":"2028_CR37","doi-asserted-by":"publisher","first-page":"W310","DOI":"10.1093\/nar\/gkad407","volume":"51","author":"Y Lu","year":"2023","unstructured":"Lu Y, Zhou G, Ewald J, Pang Z, Shiri T, Xia J. MicrobiomeAnalyst 2.0: comprehensive statistical, functional and integrative analysis of microbiome data. Nucleic Acids Res. 2023;51(W1):W310\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2028_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, Burovski E, Peterson P, Weckesser W, Bright J, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17(3):261\u201372.","journal-title":"Nat Methods"},{"key":"2028_CR39","unstructured":"Jones E, Oliphant T, Peterson P. SciPy: open source scientific tools for Python. 2001. http:\/\/www.scipy.org\/."},{"issue":"12","key":"2028_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"5","key":"2028_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/metabo10050186","volume":"10","author":"Z Pang","year":"2020","unstructured":"Pang Z, Chong J, Li S, Xia J. MetaboAnalystR 3.0: toward an optimized workflow for global metabolomics. Metabolites. 2020;10(5):186.","journal-title":"Metabolites"},{"issue":"1","key":"2028_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"key":"2028_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-981-15-6407-9_10","volume":"1278","author":"Y Liu","year":"2021","unstructured":"Liu Y, Tran DQ, Lindsey JW, Rhoads JM. The association of gut microbiota and Treg dysfunction in autoimmune diseases. Adv Exp Med Biol. 2021;1278:191\u2013203.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2028_CR44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"key":"2028_CR45","first-page":"11","volume":"10","author":"D Berman","year":"2010","unstructured":"Berman D, Parker SM, Siegel J, Chasalow SD, Weber J, Galbraith S, Targan SR, Wang HL. Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma. Cancer Immun. 2010;10:11.","journal-title":"Cancer Immun"},{"issue":"5","key":"2028_CR46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","volume":"3","author":"EA Tivol","year":"1995","unstructured":"Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3(5):541\u20137.","journal-title":"Immunity"},{"issue":"5238","key":"2028_CR47","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.270.5238.985","volume":"270","author":"P Waterhouse","year":"1995","unstructured":"Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995;270(5238):985\u20138.","journal-title":"Science"},{"issue":"3","key":"2028_CR48","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41591-024-02803-3","volume":"30","author":"JR Bjork","year":"2024","unstructured":"Bjork JR, Bolte LA, Maltez Thomas A, Lee KA, Rossi N, Wind TT, Smit LM, Armanini F, Asnicar F, Blanco-Miguez A, et al. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma. Nat Med. 2024;30(3):785\u201396.","journal-title":"Nat Med"},{"issue":"3","key":"2028_CR49","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41591-024-02823-z","volume":"30","author":"A Gunjur","year":"2024","unstructured":"Gunjur A, Shao Y, Rozday T, Klein O, Mu A, Haak BW, Markman B, Kee D, Carlino MS, Underhill C, et al. A gut microbial signature for combination immune checkpoint blockade across cancer types. Nat Med. 2024;30(3):797\u2013809.","journal-title":"Nat Med"},{"issue":"1","key":"2028_CR50","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1038\/s41467-023-42997-7","volume":"14","author":"R Liu","year":"2023","unstructured":"Liu R, Zou Y, Wang WQ, Chen JH, Zhang L, Feng J, Yin JY, Mao XY, Li Q, Luo ZY, et al. Gut microbial structural variation associates with immune checkpoint inhibitor response. Nat Commun. 2023;14(1):7421.","journal-title":"Nat Commun"},{"issue":"3","key":"2028_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-022-01695-5","volume":"28","author":"KA Lee","year":"2022","unstructured":"Lee KA, Thomas AM, Bolte LA, Bjork JR, de Ruijter LK, Armanini F, Asnicar F, Blanco-Miguez A, Board R, Calbet-Llopart N, et al. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat Med. 2022;28(3):535\u201344.","journal-title":"Nat Med"},{"issue":"6529","key":"2028_CR52","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar D, Dzutsev AK, McCulloch JA, Rodrigues RR, Chauvin JM, Morrison RM, Deblasio RN, Menna C, Ding Q, Pagliano O, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science. 2021;371(6529):595\u2013602.","journal-title":"Science"},{"issue":"6529","key":"2028_CR53","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, Ortenberg R, Lahat A, Katz L, Adler K, Dick-Necula D, Raskin S, Bloch N, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371(6529):602\u20139.","journal-title":"Science"},{"key":"2028_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10391","volume":"7","author":"K Dubin","year":"2016","unstructured":"Dubin K, Callahan MK, Ren B, Khanin R, Viale A, Ling L, No D, Gobourne A, Littmann E, Huttenhower C, et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun. 2016;7: 10391.","journal-title":"Nat Commun"},{"issue":"5","key":"2028_CR55","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2217\/imt-2018-0144","volume":"11","author":"T Liu","year":"2019","unstructured":"Liu T, Xiong Q, Li L, Hu Y. Intestinal microbiota predicts lung cancer patients at risk of immune-related diarrhea. Immunotherapy. 2019;11(5):385\u201396.","journal-title":"Immunotherapy"},{"key":"2028_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.763468","volume":"11","author":"K Sakai","year":"2021","unstructured":"Sakai K, Sakurai T, De Velasco MA, Nagai T, Chikugo T, Ueshima K, Kura Y, Takahama T, Hayashi H, Nakagawa K, et al. Intestinal microbiota and gene expression reveal similarity and dissimilarity between immune-mediated colitis and ulcerative colitis. Front Oncol. 2021;11: 763468.","journal-title":"Front Oncol"},{"issue":"3","key":"2028_CR57","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41591-022-01698-2","volume":"28","author":"JA McCulloch","year":"2022","unstructured":"McCulloch JA, Davar D, Rodrigues RR, Badger JH, Fang JR, Cole AM, Balaji AK, Vetizou M, Prescott SM, Fernandes MR, et al. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. Nat Med. 2022;28(3):545\u201356.","journal-title":"Nat Med"},{"issue":"1","key":"2028_CR58","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1073\/pnas.1712901115","volume":"115","author":"F Wang","year":"2018","unstructured":"Wang F, Yin Q, Chen L, Davis MM. Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade. Proc Natl Acad Sci U S A. 2018;115(1):157\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"2028_CR59","doi-asserted-by":"publisher","first-page":"27509","DOI":"10.1073\/pnas.1921223117","volume":"117","author":"S Sun","year":"2020","unstructured":"Sun S, Luo L, Liang W, Yin Q, Guo J, Rush AM, Lv Z, Liang Q, Fischbach MA, Sonnenburg JL, et al. Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade. Proc Natl Acad Sci U S A. 2020;117(44):27509\u201315.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2028_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01235","volume":"10","author":"T Wang","year":"2019","unstructured":"Wang T, Zheng N, Luo Q, Jiang L, He B, Yuan X, Shen L. Probiotics lactobacillus reuteri abrogates immune checkpoint blockade-associated colitis by inhibiting group 3 innate lymphoid cells. Front Immunol. 2019;10: 1235.","journal-title":"Front Immunol"},{"issue":"4","key":"2028_CR61","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000000360","volume":"7","author":"MK Fasanello","year":"2020","unstructured":"Fasanello MK, Robillard KT, Boland PM, Bain AJ, Kanehira K. Use of fecal microbial transplantation for immune checkpoint inhibitor colitis. ACG Case Rep J. 2020;7(4): e00360.","journal-title":"ACG Case Rep J"},{"key":"2028_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.913217","volume":"12","author":"M Chen","year":"2022","unstructured":"Chen M, Liu M, Li C, Peng S, Li Y, Xu X, Sun M, Sun X. Fecal microbiota transplantation effectively cures a patient with severe bleeding immune checkpoint inhibitor-associated colitis and a short review. Front Oncol. 2022;12: 913217.","journal-title":"Front Oncol"},{"issue":"12","key":"2028_CR63","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/s41591-018-0238-9","volume":"24","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med. 2018;24(12):1804\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"2028_CR64","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1987783","volume":"13","author":"J Yang","year":"2021","unstructured":"Yang J, Li Y, Wen Z, Liu W, Meng L, Huang H. Oscillospira - a candidate for the next-generation probiotics. Gut Microbes. 2021;13(1): 1987783.","journal-title":"Gut Microbes"},{"issue":"1","key":"2028_CR65","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/j.gastro.2021.09.061","volume":"162","author":"SF Lima","year":"2022","unstructured":"Lima SF, Gogokhia L, Viladomiu M, Chou L, Putzel G, Jin WB, Pires S, Guo CJ, Gerardin Y, Crawford CV, et al. Transferable immunoglobulin a-coated Odoribacter splanchnicus in responders to fecal microbiota transplantation for ulcerative colitis limits colonic inflammation. Gastroenterology. 2022;162(1):166\u201378.","journal-title":"Gastroenterology"},{"issue":"4","key":"2028_CR66","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/microorganisms8040573","volume":"8","author":"M Vacca","year":"2020","unstructured":"Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The controversial role of human gut Lachnospiraceae. Microorganisms. 2020;8(4):573.","journal-title":"Microorganisms"},{"issue":"11","key":"2028_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260451","volume":"16","author":"M Hirayama","year":"2021","unstructured":"Hirayama M, Nishiwaki H, Hamaguchi T, Ito M, Ueyama J, Maeda T, Kashihara K, Tsuboi Y, Ohno K. Intestinal collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate. PLoS ONE. 2021;16(11): e0260451.","journal-title":"PLoS ONE"},{"issue":"6","key":"2028_CR68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3892\/ol.2020.12190","volume":"20","author":"SC Chang","year":"2020","unstructured":"Chang SC, Shen MH, Liu CY, Pu CM, Hu JM, Huang CJ. A gut butyrate-producing bacterium Butyricicoccus pullicaecorum regulates short-chain fatty acid transporter and receptor to reduce the progression of 1,2-dimethylhydrazine-associated colorectal cancer. Oncol Lett. 2020;20(6):327.","journal-title":"Oncol Lett"},{"issue":"6","key":"2028_CR69","doi-asserted-by":"publisher","first-page":"e00094","DOI":"10.1128\/msystems.00094-18","volume":"3","author":"L Boesmans","year":"2018","unstructured":"Boesmans L, Valles-Colomer M, Wang J, Eeckhaut V, Falony G, Ducatelle R, Van Immerseel F, Raes J, Verbeke K. Butyrate producers as potential next-generation probiotics: safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers. mSystems. 2018;3(6):e00094.","journal-title":"mSystems"},{"issue":"1","key":"2028_CR70","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41420-022-01015-3","volume":"8","author":"Z Zhan","year":"2022","unstructured":"Zhan Z, Liu W, Pan L, Bao Y, Yan Z, Hong L. Overabundance of Veillonella parvula promotes intestinal inflammation by activating macrophages via LPS-TLR4 pathway. Cell Death Discov. 2022;8(1):251.","journal-title":"Cell Death Discov"},{"key":"2028_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.598152","volume":"11","author":"RV Cortez","year":"2020","unstructured":"Cortez RV, Moreira LN, Padilha M, Bibas MD, Toma RK, Porta G, Taddei CR. Gut microbiome of children and adolescents with primary sclerosing cholangitis in association with ulcerative colitis. Front Immunol. 2020;11: 598152.","journal-title":"Front Immunol"},{"issue":"11","key":"2028_CR72","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216504","volume":"80","author":"SX Zhang","year":"2021","unstructured":"Zhang SX, Wang J, Chen JW, Zhang MX, Zhang YF, Hu FY, Lv ZQ, Gao C, Li YF, Li XF. The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus. Ann Rheum Dis. 2021;80(11): e177.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2028_CR73","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41564-019-0649-5","volume":"5","author":"E Zagato","year":"2020","unstructured":"Zagato E, Pozzi C, Bertocchi A, Schioppa T, Saccheri F, Guglietta S, Fosso B, Melocchi L, Nizzoli G, Troisi J, et al. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat Microbiol. 2020;5(3):511\u201324.","journal-title":"Nat Microbiol"},{"key":"2028_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10: 277.","journal-title":"Front Immunol"},{"issue":"7480","key":"2028_CR75","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446\u201350.","journal-title":"Nature"},{"issue":"4","key":"2028_CR76","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1039\/D2FO03396H","volume":"14","author":"S Chudan","year":"2023","unstructured":"Chudan S, Ishibashi R, Nishikawa M, Tabuchi Y, Nagai Y, Ikushiro S, Furusawa Y. Effect of soluble oat fiber on intestinal microenvironment and TNBS-induced colitis. Food Funct. 2023;14(4):2188\u201399.","journal-title":"Food Funct"},{"issue":"1","key":"2028_CR77","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/s41467-021-25081-w","volume":"12","author":"TPN Bui","year":"2021","unstructured":"Bui TPN, Manneras-Holm L, Puschmann R, Wu H, Troise AD, Nijsse B, Boeren S, Backhed F, Fiedler D, deVos WM. Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health. Nat Commun. 2021;12(1):4798.","journal-title":"Nat Commun"},{"key":"2028_CR78","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaut.2019.01.008","volume":"98","author":"M Pellicciotta","year":"2019","unstructured":"Pellicciotta M, Rigoni R, Falcone EL, Holland SM, Villa A, Cassani B. The microbiome and immunodeficiencies: lessons from rare diseases. J Autoimmun. 2019;98:132\u201348.","journal-title":"J Autoimmun"},{"key":"2028_CR79","doi-asserted-by":"crossref","unstructured":"Hajjar J, Voigt A, Conner M, Swennes A, Fowler S, Calarge C, Mendonca D, Armstrong D, Chang CY, Walter J et al. Common variable immunodeficiency patient fecal microbiota transplant recapitulates gut dysbiosis. Res Sq [Preprint]. 2023:rs.3.rs-2640584.","DOI":"10.21203\/rs.3.rs-2640584\/v1"},{"issue":"3","key":"2028_CR80","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molcel.2020.09.006","volume":"80","author":"W Wang","year":"2020","unstructured":"Wang W, Zou W. Amino acids and their transporters in T cell immunity and cancer therapy. Mol Cell. 2020;80(3):384\u201395.","journal-title":"Mol Cell"},{"issue":"12","key":"2028_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114277","volume":"9","author":"B van den Bogert","year":"2014","unstructured":"van den Bogert B, Meijerink M, Zoetendal EG, Wells JM, Kleerebezem M. Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota. PLoS ONE. 2014;9(12): e114277.","journal-title":"PLoS ONE"},{"issue":"48","key":"2028_CR82","doi-asserted-by":"publisher","first-page":"16917","DOI":"10.1073\/pnas.0407457101","volume":"101","author":"PG Egland","year":"2004","unstructured":"Egland PG, Palmer RJ Jr, Kolenbrander PE. Interspecies communication in Streptococcus gordonii-Veillonella atypica biofilms: signaling in flow conditions requires juxtaposition. Proc Natl Acad Sci U S A. 2004;101(48):16917\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2028_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/jips.jips_183_17","volume":"18","author":"BM Nedumgottil","year":"2018","unstructured":"Nedumgottil BM. Relative presence of Streptococcus mutans, Veillonella atypica, and Granulicatella adiacens in biofilm of complete dentures. J Indian Prosthodont Soc. 2018;18(1):24\u20138.","journal-title":"J Indian Prosthodont Soc"},{"issue":"3","key":"2028_CR84","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/ajcn\/41.3.639","volume":"41","author":"SD Krasinski","year":"1985","unstructured":"Krasinski SD, Russell RM, Furie BC, Kruger SF, Jacques PF, Furie B. The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr. 1985;41(3):639\u201343.","journal-title":"Am J Clin Nutr"},{"key":"2028_CR85","doi-asserted-by":"crossref","unstructured":"Hu S, Ma Y, Xiong K, Wang Y, Liu Y, Sun Y, Yang Y, Ma A. Ameliorating effects of vitamin K2 on dextran sulfate sodium-induced ulcerative colitis in mice. Int J Mol Sci. 2023;24(3):2986.","DOI":"10.3390\/ijms24032986"}],"updated-by":[{"DOI":"10.1186\/s40168-025-02069-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000}}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-025-02028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-025-02028-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-025-02028-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T12:37:48Z","timestamp":1742042268000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-025-02028-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2028"],"URL":"https:\/\/doi.org\/10.1186\/s40168-025-02028-7","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised:  At the end ofIn the Abstract, Conclusions section \u201cta\u201d should be \u201ctargets\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s40168-025-02069-y","URL":"https:\/\/doi.org\/10.1186\/s40168-025-02069-y","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NIH cohort\n                      Healthy individuals and patients with CTLA4-D provided informed consent in accordance with the Declaration of Helsinki and were enrolled into the National Institute of Allergy and Infectious Diseases (NIAID) Institutional Review Board (IRB)-approved protocol 93-I-0119 \u2014 Detection and Characterization of Host Defense Defects (ClinicalTrials.gov:\n                      \n                      ), a prospective longitudinal observational cohort study.\n                      CCI cohort\n                      Healthy individuals and patients with CTLA4-D or CVID were recruited; patient consent was collected by the treating physicians, and samples were processed at the Uniklinik Freiburg under the ethics-approved protocols 526\/14, 295\/13_140782, and 60\/18.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}